Investor Presentation H1 2023

121 Investor presentation First six months of 2023 Diabetes market share and market growth in EMEA 75% 50% 25% Diabetes market growth and Novo Nordisk market share 0% May 2020 NN market share -Market growth (right axis) DKK billion 20% 17% 106 15% 15% Diabetes market size and growth EMEA ~15% 5 122 6 LO 5 33... 10% 30% 5% ~17% 30% 29% 0% May 2023 May 2022 NN Company A Others May 2023 Novo Nordisk Competitors NN share of growth NN growth (right axis) Source: IQVIA, May 2023, Value, MAT; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. EMEA: Europe, Middle East and Africa; NN: Novo Nordisk

View entire presentation